New drugs for neglected infectious diseases: Chagas' disease

British Journal of Pharmacology

Volumn 160, Issue 2, 2010, Pages 258-259

  MacHado, Fabiana S ^a   Tanowitz, Herbert B ^b   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anti microbial; Chagas disease; Neglected diseases; Nitric oxide; Trypanosoma cruzi

Indexed keywords

ANTIARRHYTHMIC AGENT; BENZNIDAZOLE; NIFURTIMOX; NITRIC OXIDE; NITRIC OXIDE DONOR; RUTHENIUM COMPLEX;

ANTIPROTOZOAL ACTIVITY; CHAGAS DISEASE; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; HEART TRANSPLANTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NOTE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE INJURY; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; HUMANS; NIFURTIMOX; NITRIC OXIDE DONORS; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 77951694550     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00662.x     Document Type: Note

References (16)

1. Chan J, Flynn J (2004). The immunological aspects of latency in tuberculosis. Clin Immunol 110 : 2 12. (Pubitemid 38177416)
2. Dutra WO, Rocha MO, Teixeira MM (2005). The clinical immunology of human Chagas disease. Trends Parasitol 21 : 581 587.
3. Filardi LS, Brener Z (1987). Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81 : 755 759. (Pubitemid 18070985)
4. Godoy HL, Guerra CM, Viegas RF, Dinis RZ, Branco JN, Neto VA et al. (2009). Infections in heart transplant recipients in Brazil: the challenge of Chagas' disease. J Heart Lung Transplant 29 : 286 290
5. Guedes MM, Oliveira FS, Gutierrez FRS, da Silva GK, Rodrigues GJ, Bendhack LM et al. (2010). Nitric oxide donor trans-[RuCl([15]aneN4)NO]2+ as a possible therapeutic approach for Chagas disease. Br J Pharmacol. 160 : 270 282.
6. Guido RVC, Oliva G, Montanari CA, Andricopulo AD (2008). Structural basis selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies. J Chem Inf Model 48 : 918 929. (Pubitemid 351757757)
7. Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, Factor SM et al. (1999). Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 31 : 75 88. (Pubitemid 29078220)
8. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS (2000). Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102 : 3003 3008.
9. Machado FS, Koyama NS, Carregaro V, Ferreira BR, Milanezi CM, Teixeira MM et al. (2005). CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 191 : 627 636. (Pubitemid 40216680)
10. Rocha MO, Teixeira MM, Ribeiro AL (2007). An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 5 : 727 743.
11. Silva JJN, Guedes PMM, Zottis A, Balliano TL, Silva FON, Lopes LGF et al. (2010). Novel ruthenium complexes as potential drugs for Chagas' disease: enzyme inhibition, and in vitro/in vivo trypanocidal activity. Br J Pharmacol. 160 : 260 269.
12. Silva JS, Machado FS, Martins GA (2003). The role of nitric oxide in the pathogenesis of Chagas disease. Front Biosci 8 : S314 S325.
13. Souza DHF, Garratt RC, Araújo APU, Guimarães BG, Jesus WDP, Michels PAM et al. (1998). Trypanosoma cruzi glycosomal glyceraldehyde-3- phasphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design. FEBS Lett 424 : 131 135.
14. Talvani A, Machado FS, Santana GC, Klein A, Barcelos L, Silva JS et al. (2002). Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect Immun 70 : 4247 4253. (Pubitemid 34790933)
15. Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC et al. (2009). Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 51 : 524 539.
16. Verline CLMJ, Hannaert V, Blonski C, Wilison M, Périé JJ, Fathergill-Gilmore LA et al. (2001). Glycolysis as target for the design of new anti-trypanosome drugs. Drug Resist Updat 4 : 1 14. (Pubitemid 32267825)